Xtl Biopharmaceuticals (XTLB) Cash from Financing Activities (2010 - 2015)
Xtl Biopharmaceuticals (XTLB) reported Cash from Financing Activities of $208,000 for the year ended Dec 31, 2025, down 85.6% from $1.45 million a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Cash from Financing Activities (2010 - 2015) Analysis & Trends
Dating back to the year ended Dec 31, 2010, Xtl Biopharmaceuticals' Cash from Financing Activities record includes 10 years.
- Cash from Financing Activities has a four-year compound annual growth rate of -14.3% (years ended Dec 2021 to Dec 2025).
- The figure for the year ended Dec 31, 2025 ranks as the lowest annual Cash from Financing Activities in data going back to the year ended Dec 31, 2010.
- According to Business Quant data, Cash from Financing Activities came in at $1.45 million in the year ended Dec 31, 2024 and $385,000 in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Xtl Biopharmaceuticals | 2.27 Bn | 2.27 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 20,000.00 |
| Jun 30, 2015 | 3.56 Mn |
| Sep 30, 2014 | 13,000.00 |
| Jun 30, 2014 | 66,000.00 |
| Mar 31, 2014 | 230,000.00 |
| Dec 31, 2013 | 172,000.00 |
| Sep 30, 2013 | 127,000.00 |
| Jun 30, 2013 | 9,000.00 |
| Mar 31, 2013 | 9,000.00 |
| Dec 31, 2012 | 82,000.00 |
| Sep 30, 2012 | 395,000.00 |
| Jun 30, 2012 | 36,000.00 |
| Mar 31, 2012 | 3.77 Mn |
| Sep 30, 2011 | -7,000.00 |
| Jun 30, 2011 | -15,000.00 |
| Mar 31, 2011 | 1.77 Mn |
| Dec 31, 2010 | 7,000.00 |
| Sep 30, 2010 | 1.47 Mn |
API Access
Xtl Biopharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();